JUNSHI BIO (01877): The Strategic Committee is adjusted to the Strategic and ESG Committee.

date
19:58 13/03/2026
avatar
GMT Eight
Jinshi Biology (01877) announced that in order to further enhance the company's environmental, social, and corporate governance (ESG) management level and strengthen the company's sustainable development capabilities, in accordance with relevant laws and the company's articles of association, and based on the company's actual situation, the board of directors has decided to adjust the original strategic committee to the strategic and ESG committee, effective from March 13, 2026. The original "Regulations of the Strategic Committee" will be adjusted to the "Regulations of the Strategic and ESG Committee," adding responsibilities such as ESG management on the basis of the original authority.
JUNSHI BIO (01877) Announcement: In order to further enhance the company's environmental, social, and corporate governance (ESG) management capabilities, strengthen the company's sustainable development capabilities, and in accordance with relevant laws and the company's articles of association, taking into account the actual situation of the company, the Board of Directors has resolved to adjust the former Strategic Committee to the Strategic and ESG Committee, effective from March 13, 2026. The former "Strategic Committee working rules" will be adjusted to the "Strategic and ESG Committee working rules", with additional responsibilities in ESG management based on the original authority. The Strategic and ESG Committee is mainly responsible for researching the company's long-term development strategy, significant investment decisions, sustainable development, and ESG, and providing recommendations to the Board of Directors. This adjustment only pertains to the name and responsibilities of the committee, with no changes to its composition, term limits, etc.